Dalbavancin Market 2027 by Type, Applications | The Insight Partners

Dalbavancin Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Type (Intravenous Therapy, Oral Type); Applications (Skin Infection, Soft Tissue Infection, Others)

Report Code: TIPRE00008172 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Dalbavancin is an antibiotic used to treat severe bacterial skin and skin structure infections in adults caused by sensitive gram-positive organisms, including methicillin-resistant Staphylococcus aureus (MRSA). MRSA infections have become doubtful in the community and healthcare settings due to resistance to many available antibiotics. Because dalbavancin has shown efficacy against MRSA and other microorganisms to treat severe or life-threatening infections and it was the first drug approved.

MARKET DYNAMICS

The dalbavancin market is anticipated to increase in the market owing to the rise in technology. However, the increase in awareness about the presence of dalbavancin antibiotics has lowered ignorance, which is restraining the market growth. Moreover, the rising geriatric population has driven the market in the forecast period.

MARKET SCOPE

The "Dalbavancin Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in dalbavancin market with detailed market segmentation by type, application and geography. The dalbavancin market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in dalbavancin market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The dalbavancin market is segmented on the basis of type and application. Based on type the market is segmented as intravenous therapy and oral type. On the basis of application the market is categorized as skin infection, soft tissue infection and others.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in dalbavancin market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The dalbavancin market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting dalbavancin market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the dalbavancin market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in dalbavancin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in dalbavancin market are anticipated to have lucrative growth opportunities in the future with the rising demand for in dalbavancin market in the global market. Below mentioned is the list of few companies engaged in the dalbavancin market.

The report also includes the profiles of key in dalbavancin market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  AbbVie Inc.
  •  Amgen Inc.
  •  F. Hoffmann-La Roche Ltd
  •  Gilead Sciences, Inc.
  •  GlaxoSmithKline plc
  •  Johnson & Johnson Services, Inc.
  •  Merck & Co.
  •  Novartis AG
  •  Pfizer Inc.
  •  Sanofi

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Dalbavancin Market - By Type
1.3.2 Dalbavancin Market - By Applications
1.3.3 Dalbavancin Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY


4. DALBAVANCIN MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. DALBAVANCIN MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. DALBAVANCIN MARKET - GLOBAL MARKET ANALYSIS

6.1. DALBAVANCIN - GLOBAL MARKET OVERVIEW
6.2. DALBAVANCIN - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. DALBAVANCIN MARKET - REVENUE AND FORECASTS TO 2027 - TYPE

7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. INTRAVENOUS THERAPY
7.3.1. Overview
7.3.2. Intravenous Therapy Market Forecast and Analysis
7.4. ORAL TYPE
7.4.1. Overview
7.4.2. Oral Type Market Forecast and Analysis

8. DALBAVANCIN MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATIONS

8.1. OVERVIEW
8.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. SKIN INFECTION
8.3.1. Overview
8.3.2. Skin Infection Market Forecast and Analysis
8.4. SOFT TISSUE INFECTION
8.4.1. Overview
8.4.2. Soft Tissue Infection Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis

9. DALBAVANCIN MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

9.1. NORTH AMERICA
9.1.1 North America Dalbavancin Market Overview
9.1.2 North America Dalbavancin Market Forecasts and Analysis
9.1.3 North America Dalbavancin Market Forecasts and Analysis - By Type
9.1.4 North America Dalbavancin Market Forecasts and Analysis - By Applications
9.1.5 North America Dalbavancin Market Forecasts and Analysis - By Countries
9.1.5.1 United States Dalbavancin Market
9.1.5.1.1 United States Dalbavancin Market by Type
9.1.5.1.2 United States Dalbavancin Market by Applications
9.1.5.2 Canada Dalbavancin Market
9.1.5.2.1 Canada Dalbavancin Market by Type
9.1.5.2.2 Canada Dalbavancin Market by Applications
9.1.5.3 Mexico Dalbavancin Market
9.1.5.3.1 Mexico Dalbavancin Market by Type
9.1.5.3.2 Mexico Dalbavancin Market by Applications
9.2. EUROPE
9.2.1 Europe Dalbavancin Market Overview
9.2.2 Europe Dalbavancin Market Forecasts and Analysis
9.2.3 Europe Dalbavancin Market Forecasts and Analysis - By Type
9.2.4 Europe Dalbavancin Market Forecasts and Analysis - By Applications
9.2.5 Europe Dalbavancin Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Dalbavancin Market
9.2.5.1.1 Germany Dalbavancin Market by Type
9.2.5.1.2 Germany Dalbavancin Market by Applications
9.2.5.2 France Dalbavancin Market
9.2.5.2.1 France Dalbavancin Market by Type
9.2.5.2.2 France Dalbavancin Market by Applications
9.2.5.3 Italy Dalbavancin Market
9.2.5.3.1 Italy Dalbavancin Market by Type
9.2.5.3.2 Italy Dalbavancin Market by Applications
9.2.5.4 Spain Dalbavancin Market
9.2.5.4.1 Spain Dalbavancin Market by Type
9.2.5.4.2 Spain Dalbavancin Market by Applications
9.2.5.5 United Kingdom Dalbavancin Market
9.2.5.5.1 United Kingdom Dalbavancin Market by Type
9.2.5.5.2 United Kingdom Dalbavancin Market by Applications
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Dalbavancin Market Overview
9.3.2 Asia-Pacific Dalbavancin Market Forecasts and Analysis
9.3.3 Asia-Pacific Dalbavancin Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Dalbavancin Market Forecasts and Analysis - By Applications
9.3.5 Asia-Pacific Dalbavancin Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Dalbavancin Market
9.3.5.1.1 Australia Dalbavancin Market by Type
9.3.5.1.2 Australia Dalbavancin Market by Applications
9.3.5.2 China Dalbavancin Market
9.3.5.2.1 China Dalbavancin Market by Type
9.3.5.2.2 China Dalbavancin Market by Applications
9.3.5.3 India Dalbavancin Market
9.3.5.3.1 India Dalbavancin Market by Type
9.3.5.3.2 India Dalbavancin Market by Applications
9.3.5.4 Japan Dalbavancin Market
9.3.5.4.1 Japan Dalbavancin Market by Type
9.3.5.4.2 Japan Dalbavancin Market by Applications
9.3.5.5 South Korea Dalbavancin Market
9.3.5.5.1 South Korea Dalbavancin Market by Type
9.3.5.5.2 South Korea Dalbavancin Market by Applications
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Dalbavancin Market Overview
9.4.2 Middle East and Africa Dalbavancin Market Forecasts and Analysis
9.4.3 Middle East and Africa Dalbavancin Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Dalbavancin Market Forecasts and Analysis - By Applications
9.4.5 Middle East and Africa Dalbavancin Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Dalbavancin Market
9.4.5.1.1 South Africa Dalbavancin Market by Type
9.4.5.1.2 South Africa Dalbavancin Market by Applications
9.4.5.2 Saudi Arabia Dalbavancin Market
9.4.5.2.1 Saudi Arabia Dalbavancin Market by Type
9.4.5.2.2 Saudi Arabia Dalbavancin Market by Applications
9.4.5.3 U.A.E Dalbavancin Market
9.4.5.3.1 U.A.E Dalbavancin Market by Type
9.4.5.3.2 U.A.E Dalbavancin Market by Applications
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Dalbavancin Market Overview
9.5.2 South and Central America Dalbavancin Market Forecasts and Analysis
9.5.3 South and Central America Dalbavancin Market Forecasts and Analysis - By Type
9.5.4 South and Central America Dalbavancin Market Forecasts and Analysis - By Applications
9.5.5 South and Central America Dalbavancin Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Dalbavancin Market
9.5.5.1.1 Brazil Dalbavancin Market by Type
9.5.5.1.2 Brazil Dalbavancin Market by Applications
9.5.5.2 Argentina Dalbavancin Market
9.5.5.2.1 Argentina Dalbavancin Market by Type
9.5.5.2.2 Argentina Dalbavancin Market by Applications

10. INDUSTRY LANDSCAPE

10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. DALBAVANCIN MARKET, KEY COMPANY PROFILES

11.1. ABBVIE INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. AMGEN INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. F. HOFFMANN-LA ROCHE LTD
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GILEAD SCIENCES, INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GLAXOSMITHKLINE PLC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. JOHNSON AND JOHNSON SERVICES, INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MERCK AND CO.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. NOVARTIS AG
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. PFIZER INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SANOFI
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX

12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. AbbVie Inc.
2. Amgen Inc.
3. F. Hoffmann-La Roche Ltd
4. Gilead Sciences, Inc.
5. GlaxoSmithKline plc
6. Johnson & Johnson Services, Inc.
7. Merck & Co.
8. Novartis AG
9. Pfizer Inc.
10. Sanofi
TIPRE00008172
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking